Journal of Shandong University (Health Sciences) ›› 2023, Vol. 61 ›› Issue (1): 45-50.doi: 10.6040/j.issn.1671-7554.0.2022.1013
• 临床医学 • Previous Articles
YU Wenhao, ZHANG Qian, SUN Mei, LI Hongchang, ZHU Yueting, JIANG Wenjie, YAN Junhao
CLC Number:
[1] Källén B, Finnström O, Lindam A, et al. Trends in delivery and neonatal outcome after in vitro fertilization in Sweden: data for 25 years[J]. Hum Reprod, 2010, 25(4):1026-1034. [2] Luke B. Pregnancy and birth outcomes in couples with infertility with and without assisted reproductive technology: with an emphasis on US population-based studies[J]. Am J Obstet Gynecol, 2017, 217(3): 270-281. [3] 胡琳莉, 黄国宁, 孙海翔, 等. 促排卵药物使用规范(2016)[J]. 生殖医学杂志, 2017, 26(4): 302-307. HU Linli, HUANG Guoning, SUN Haixiang, et al. CSRM guideline for the use of ovulation induction drug(2016)[J]. Journal of Reproductive Medicine, 2017, 26(4): 302-307. [4] Filicori M, Cognigni GE, Arnone R, et al. Role of different GnRH agonist regimens in pituitary suppression and the outcome of controlled ovarian hyperstimulation [J]. Hum Reprod, 1996, 11(Suppl 3): 123-132. [5] Wei D, Liu JY, Sun Y, et al. Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial[J]. Lancet, 2019, 393(10178): 1310-1318. [6] Shi Y, Sun Y, Hao C, et al. Transfer of fresh versus frozen embryos in ovulatory women [J]. N Engl J Med, 2018, 378(2): 126-136. [7] Mizrachi Y, Horowitz E, Farhi J, et al. Ovarian stimulation for freeze-all IVF cycles: a systematic review [J]. Hum Reprod Update, 2020, 26(1): 118-135. [8] Capalbo A, Rienzi L, Cimadomo D, et al. Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts [J]. Hum Reprod, 2014, 29(6): 1173-1181. [9] Mumusoglu S, Yarali I, Bozdag G, et al. Time-lapse morphokinetic assessment has low to moderate ability to predict euploidy when patient- and ovarian stimulation-related factors are taken into account with the use of clustered data analysis[J]. Fertil Steril, 2017, 107(2): 413-421. [10] Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. The use of preimplantation genetic testing for aneuploidy(PGT-A): a committee opinion[J]. Fertil Steril, 2018,109(3): 429-436. [11] Dahdouh EM, Balayla J, Garcia-Velasco JA, et al. PGT-A for recurrent pregnancy loss: evidence is growing but the issue is not resolved[J]. Hum Reprod, 2021, 36(10): 2805-2806. [12] Poseidon Group(Patient-Oriented Strategies Encompassing Individualized Oocyte Number), Alviggi C, Andersen CY, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept[J]. Fertil Steril, 2016, 105(6): 1452-1453. [13] Ovarian Stimulation TEGGO, Bosch E, Broer S, et al. ESHRE guideline: ovarian stimulation for IVF/ICSI[J]. Hum Reprod Open, 2020,2020(2): hoaa009. doi: 10.1093/hropen/hoaa009. eCollection 2020. [14] Al-Inany HG, Youssef MA, Ayeleke RO, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology[J]. Cochrane Database Syst Rev, 2016, 4(4): CD001750. doi: 10.1002/14651858.CD001750. [15] Gardner DK, Lane M, Stevens J, et al. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer[J]. Fertil Steril, 2000, 73(6): 1155-1158. [16] 中国女医师协会生殖医学专业委员会专家共识编写组. 辅助生殖领域拮抗剂方案标准化应用专家共识[J]. 中华生殖与避孕杂志, 2022, 42(2): 109-116. [17] Xu DF, Liu PP, Fan L, et al. GnRH antagonist weakens endometrial stromal cells growth ability by decreasing c-kit receptor expression[J]. Reprod Biol Endocrinol, 2022, 20(1): 29. doi: 10.1186/s12958-021-00886-y. [18] Rivier J, Jiang GC, Lahrichi SL, et al. Dose relationship between GnRH antagonists and pituitary suppression. Human reproduction[J]. 1996, 11(Suppl 3): 133-147. [19] Yang WJ, Hwang YC, Lin CS, et al. Embryonic early-cleavage rate is decreased with aging in GnRH agonist but not in antagonist protocols[J]. J Assist Reprod Genet, 2015, 32(5): 789-795. [20] Bahçeci M, Ulug U, Erden HF, et al. Frozen-thawed cleavage-stage embryo transfer cycles after previous GnRH agonist or antagonist stimulation[J]. Reprod Biomed Online, 2009, 18(1): 67-72. [21] Abbara A, Clarke SA, Dhillo WS. Novel concepts for inducing final oocyte maturation in in vitro fertilization treatment[J]. Endocr Rev, 2018, 39(5): 593-628. [22] Wu Q, Li H, Zhu Y, et al. Dosage of exogenous gonadotropins is not associated with blastocyst an-euploidy or live-birth rates in PGS cycles in Chinese women[J]. Hum Reprod, 2018, 33(10): 1875-1882. [23] Kyrou D, Verpoest W, Staessen C, et al. No relationship between the type of pituitary suppression for IVF and chromosomal abnormality rates of blastomeres: an observational study[J]. Fertil Steril, 2011, 95(2): 563-567. [24] Labarta E, Bosch E, Mercader A, et al. A higher ovarian response after stimulation for IVF Is related to a higher number of euploid embryos[J]. Biomed Res Int, 2017, 2017: 5637923. doi: 10.1155/2017/5637923. [25] La Marca A, Capuzzo M, Longo M, et al. The number and rate of euploid blastocysts in women undergoing IVF/ICSI cycles are strongly dependent on ovarian reserve and female age[J]. Hum Reprod, 2022, 37(10): 2392-2401. |
[1] | WANG Zengmin, HAN Jinyan, LI Guimei. GnRHa in combination with rhGH in the treatment of an infantile hypothalamic hamartoma and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 48-53. |
[2] | SHI Yuhua, WANG Qiumin, QI Dan. Frontier research hotspot and progress in assisted reproductive technology [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 97-102. |
[3] | SHI Juanzi, CHEN Lijuan. Progress in assisted reproductive technology [J]. Journal of Shandong University (Health Sciences), 2019, 57(10): 1-6. |
|